A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center
Guopei Luo et al, 2015, Pancreatology CrossRef
The utility of 68Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors
Amit Tirosh et al, 2017, Future Oncology CrossRef
The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC).
Liang Liu et al, 2016, Int. J. Oncol. CrossRef
Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors
Guopei Luo et al, 2017 CrossRef
Novel PET tracers: added value for endocrine disorders
Sébastien Bergeret et al, 2019, Endocrine CrossRef
null
Mohsen Beheshti et al, 2018 CrossRef
A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival
Sara Massironi et al, 2016, Oncotarget CrossRef
Usefulness of ¹⁸ F-FDG-PET/CT in the diagnosis and prediction of recurrence of pancreatic neuroendocrine neoplasms.
Asahi Sato et al, 2020, J Hepatobiliary Pancreat Sci CrossRef
Carbohydrate antigen 19‑9 as a prognostic biomarker in pancreatic neuroendocrine tumors
Guopei Luo et al, 2017, Oncol Lett CrossRef
Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors
Diletta Calabrò et al, 2020, Diagnostics CrossRef
FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer
Shunrong Ji et al, 2016, Clin Cancer Res CrossRef
Recent Advances in Gene Therapy for Cancer Theranostics
Hannah J. Vaughan et al, 2021, Current Opinion in Biomedical Engineering CrossRef
The utility of 18F-FDG PET/CT in the diagnosis, staging of non-functioning pancreatic neuroendocrine tumors
Gihan Hassan Gamal, 2021, Egypt J Radiol Nucl Med CrossRef